Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.
The Genome Project-Write researchers are meeting again, but ScienceInsider notes that the effort is lacking funds.
The company, which is collaborating with Myeloma Crowd, will use the newly-licensed minicircle DNA technology to develop therapies for multiple myeloma.
In Science this week: a suite of studies from the Synthetic Yeast genome Project.
International research teams collaborated to create five fully functioning synthetic yeast chromosomes, taking them one step closer to a whole synthetic genome.
The collaborators hope initial research in canines can be a proving ground for synthetic viruses designed to kill particular tumors, perhaps even in humans.
Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.
In Science this week: effort to reduce E. coli genome, and more.
A new study in Scientific Reports describes how scientists were able to replace an entire gene in a bacterial genome to study its function.
The Scientist traces the career path of the J. Craig Venter Institute's Clyde Hutchinson.
Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.
St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.
St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.
In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.